Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5624764 | 0.82 | — | — | |
| SCHEMBL16145065 | 0.81 | SRC (0.33) | — | |
| SCHEMBL2161089 | 0.78 | PTGS2 (0.33) | LMNAPOLBBLM | |
| Hydrochloric Acid SCHEMBL29604330 | 0.76 | POLB (0.33) | LMNAPOLBBLM | |
| SCHEMBL28017110 | 0.74 | — | — | |
| SCHEMBL10761856 | 0.73 | AKR1C3 (0.36) | — | |
| SCHEMBL4139716 | 0.73 | L3MBTL1 (0.39) | POLBKMT2AL3MBTL1 | |
| SCHEMBL28863032 | 0.72 | L3MBTL1 (0.40) | LMNAMAPK1POLBPKMKMT2A | |
| SCHEMBL2645752 | 0.71 | — | — | |
| SCHEMBL10924163 | 0.70 | CYP2D6 (0.50) | LMNAMAPK1POLBKMT2AL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4087836-B1 | PROCESSES FOR PREPARING TRIAZOLE GLYCOLATE OXIDASE INHIBITORS | CANTERO THERAPEUTICS INC (US) | 2025-10-08 | — | — | EP | disclosed |
| CN-114945559-B | Preparation method of triazole glycollic acid oxidase inhibitor | 坎特罗治疗有限公司 | 2025-03-11 | — | — | CN | disclosed |
| CN-114945559-B | Preparation method of triazole glycollic acid oxidase inhibitor | 坎特罗治疗有限公司 | 2025-03-11 | — | — | CN | disclosed |
| EP-4087836-A1 | PROCESSES FOR PREPARING TRIAZOLE GLYCOLATE OXIDASE INHIBITORS | Cantero Therapeutics, Inc. (US) | 2022-11-16 | — | — | EP | disclosed |